This page requires Adobe Flash Player to display correctly.
This ticker requires Adobe Flash Player to display correctly.

Press Releases

2010 Press Releases

February 8, 2010 - Kinexus Bioinformatics Corporation announced the commercial release of its novel Protein Kinase Microarray with 200 recombinant human protein kinases for screening.
The microarray has wide utility including applications for drug target counter screening, to identify novel kinase substrates, establish kinase antibody specificities, and for the discovery and testing of protein kinase-protein and protein kinase-compound interactions.
February 8, 2010 - Kinexus adds a Kinase Inhibitor Compound Profiling Service (KICP) to its service portfolio.
This new service is designed to assist researchers in ascertaining the specificity of lead compounds and their mechanisms of action for the selection of better drug candidates for clinical testing.

2007 Press Releases

November 13, 2007 - Kinexus a Finalist for the "Red Herring 100 Global" Award 2007
The Most Promising Private Technology Ventures in the World to be Celebrated at Event in Seattle, Washington

2006 Press Releases

November 13, 2007 - Kinexus a Finalist for the "Red Herring 100 Global" Award 2007
The Most Promising Private Technology Ventures in the World to be Celebrated at Event in Seattle, Washington

2005 Press Releases

November 16, 2005 - Kinexus Announces Launch of KiNET Functional Proteomics Database
Proprietary Cell Signaling Database Designed with Bioinformatics Capabilities
July 21, 2005 - Kinexus Announces Six New Phospho-Site Profiling Services
Kinetworks™ Phosphoprotein Services Designed for Drug Discovery
August 04, 2005 - Kinexus Bioinformatics Corporation Announces the Appointment of Two New Directors to its Board
Senior Executives Bring Substantial Expertise and Leadership to the Kinexus Board
May 13, 2005 - Kinexus Bioinformatics Corporation Honored as a Recipient of Red Herring's Top 100 Private Companies Award
Recognizes 100 Private Companies in North America that Drive the Technology Industry's Future

2004 Press Releases

July 26, 2004 - Kinexus Validates PLK1 as a Cancer Drug Target
Polo-like Kinase-1 Inhibition Blocks B23/nucleophosmin-mediated Centrosome Duplication in Tumour Cells

2003 Press Releases

September 23, 2003 - Kinexus Receives Eligible Business Corporation (EBC) Status
Kinexus Investors can Receive a 30% Refundable Tax Credit
March 11, 2003 - Kinexus Announces the Release of New Cell Cycle Screen
New Kinetworks™ Screen Tracks 30 Proteins Involved in Cell Growth and Proliferation
July 23, 2003 - Kinexus Announces Two New Phospho-Site Screening Services
Kinetworks™ Phospho-Site Arrays Developed in Collaboration with Biosource International

2002 Press Releases

December 16, 2002 - Kinexus Study Reveals Unexpected Changes in Protein Kinase Profiles
Kinexus Study Reveals Profound Changes in Protein Kinase Composition Between Rat and Monkey Tissues as Published on the Science Magazine’s Signal Transduction Knowledge Environment
July 01, 2002 - Kinexus Introduces New Apoptosis Protein Profiling Service
Kinetworks™ Screening Service Designed to Improve Discovery Based Research
April 16, 2002 - Kinexus Appoints Chief Executive Officer
David W. Turner Named CEO and Director
September 20, 2002 - Kinexus Named a 2002 Venture All Star Company
The Pacific Northwest's Venture Event of the Year Honored Kinexus Bioinformatics Corporation as One of the Top Venture-Backed Companies in the Region
May 06, 2002 - Kinexus Bioinformatics Completes First Stage Equity Financing
Kinexus Raises $0.5 Million from a Syndicate of Investors

2000 Press Releases

1999 Press Releases

Credits